High mobility group box 1 (HMGB1) (alarmin) |
RAGE, TLR4 |
Signal to the NF-κB signaling pathway and thus contributes to the inflammatory responses in type 2 diabetes mellitus, in the genesis and pathophysiology of IR and neurodegeneration. |
Gonelevue et al., 2018; Paudel et al., 2020
|
Aβ (amyloid) |
TLR4, TLR2, NLRP3, CD36, CD14 receptor |
Aβ activates the NLRP1 and NLRP3 inflammasomes. The oligomers can disturb the functions of K+ channels, decreasing the intracellular K+ concentration and thus activating caspase-1. Increasing K+ efflux with valinomycin led to activated caspase-1 and IL-1β secretion from neurons. Aβ can also activate microglial cells in the brain through interaction with the surface receptor CD36, which induces the formation of a TLR2–TLR6 heterodimer and subsequently leads to NF-κB signaling. |
Stewart et al., 2010; Heneka et al., 2018; Venegas and Heneka, 2019
|
Chromogranin A (CGA) (an acidic protein localized in secretory vesicles) |
TLR4, CD14, or class A scavenger receptor |
The stimulation of target receptors promotes the uptake of Aβ and phagolysosome formation. Upon lysosomal rupture, cathepsin B release is instrumental in the activation of procaspase-1 that ultimately produces IL-1β. |
Lechner et al., 2004; Venegas and Heneka, 2019
|
ATP |
P2 × 7R (an ATP-gated ion channel supporting Na+ and Ca2+ influx into and K+ efflux out of the cell) |
The decrease in intracellular K+ leads to P2 × 7R-mediated NLRP3 inflammasome formation. Together with IL-1β release, NLRP3 inflammasome activation in the brain through the P2 × 7 receptor induces an increase of tau secretion in exosomes and its subsequent transmission to neurons. |
Muñoz-Planillo et al., 2013; Asai et al., 2015; Venegas and Heneka, 2019
|
Ceramide (a sphingosine-based, lipid- signaling molecule that is formed from serine and 2 fatty acids) |
NLRP3 |
Ceramide can act as an endogenous signal to caspase-1 cleavage and IL-1β secretion |
Shin et al., 2015; Venegas and Heneka, 2019
|
S100 |
RAGE |
Stimulate cell proliferation and migration and inhibit of apoptosis and differentiation, which participate in neurodegenerative processes. RAGE receptor activation leads to the activation the p38 MAPK cascade NF-κB. |
Cristóvão and Gomes, 2019; Venegas and Heneka, 2019
|
mt-DNA and cf-DNA |
TLR9 AIM2 |
Induce the release of interferon type 1 and TNF-α. Exogenous mtDNA fragments induced TLR9-mediated NF-κB activation in primary muscle cells. mtDNA increased TLR9 content in muscle cells. When cf-DNA binds to TLR, signaling occurs through MyD88, which leads to a type I IFN response. When cf-DNA binds to AIM2, caspase-1 is activated, and subsequently, IL-1β is released. |
Shin et al., 2015; Venegas and Heneka, 2017; Yuzefovych et al., 2018
|
HSPs—heat shock proteins |
PRRs (pattern recognition receptor). TLR2 and TLR4 |
Interaction with receptors leads to the induction of inflammatory cytokines such as TNF-α, IL-1β, IL-12, and GM-CSF. |
Campanella et al., 2018; Venegas and Heneka, 2019
|
Homocysteine (Hcy) |
NLRP3 |
Activation of the inflammasome with the subsequent release of interleukins. Hcy mediates the development of insulin resistance. |
Smith et al., 2018; Zhang et al., 2018
|
Glucose |
NLRP3 |
Induction of IL-1β secretion followed by increased apoptosis triggered by Fas via NF-κB and JNK and/or inhibiting insulin signaling. |
Shin et al., 2015 |
IAPP [islet amyloid polypeptide (IAPP)–amylin] |
NLRP3, CD36, and RAGE |
IAPP has cytotoxic effects; assembly of the inflammasome leads to the formation of mature IL-1β. |
Fawver et al., 2014; Shin et al., 2015
|
FFAs and their metabolites (palmitate) |
NLRP3, TLR4 |
The production of inflammatory cytokines through activation of TLR and NLRP3 contributes to the development of insulin resistance by suppressing insulin signaling. |
Shin et al., 2015 |